Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 34.41
+0.34 (1.00%)
Feb 4, 2026, 2:55 PM CST
SHA:600976 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 |
Net Income | 326.3 | 362.18 | 521.46 | 408.08 | 305.26 | 147.79 |
Depreciation & Amortization | 39.95 | 39.95 | 40.33 | 38.82 | 34.12 | 20.7 |
Other Amortization | 30.63 | 30.63 | 18.73 | 15.86 | 15.92 | 9.9 |
Loss (Gain) From Sale of Assets | 0.12 | 0.12 | -0.68 | 0.02 | -0.48 | 0.09 |
Asset Writedown & Restructuring Costs | 2.96 | 2.96 | 11.91 | 10.73 | 1.5 | 1.53 |
Loss (Gain) From Sale of Investments | -254.49 | -254.49 | -243.27 | -153.59 | -123.21 | -102.59 |
Provision & Write-off of Bad Debts | 44.74 | 44.74 | 3.47 | 10.09 | 5.4 | 0.92 |
Other Operating Activities | 89.97 | 20.82 | 16.71 | 20.41 | 10.15 | 2.06 |
Change in Accounts Receivable | 140.3 | 140.3 | -252.67 | -302.98 | 3.99 | -212.8 |
Change in Inventory | 95.64 | 95.64 | -92.82 | -140.29 | 9.96 | -94 |
Change in Accounts Payable | -261.22 | -261.22 | 258.71 | 299.01 | 4.47 | 384.39 |
Change in Other Net Operating Assets | 2.44 | 2.44 | 8.85 | 9.44 | 10.27 | - |
Operating Cash Flow | 267.53 | 234.27 | 268.39 | 215.87 | 247.92 | 125.54 |
Operating Cash Flow Growth | 29.69% | -12.72% | 24.33% | -12.93% | 97.48% | 68.62% |
Capital Expenditures | -107.08 | -120.29 | -64.5 | -67.96 | -56.15 | -45.58 |
Sale of Property, Plant & Equipment | 0.37 | 0.39 | 2.88 | 0.24 | 1.15 | 0.06 |
Divestitures | - | - | 18.94 | - | - | - |
Investment in Securities | -136.4 | -127 | -137.82 | -75.47 | 62.38 | -128.17 |
Other Investing Activities | 120.23 | - | 103.19 | - | - | 8.86 |
Investing Cash Flow | -122.88 | -246.9 | -77.31 | -143.2 | 7.38 | -164.83 |
Short-Term Debt Issued | - | - | - | 103.5 | 45 | 48 |
Long-Term Debt Issued | - | 154.8 | 79.45 | 3.2 | 10.44 | - |
Total Debt Issued | 86.1 | 154.8 | 79.45 | 106.7 | 55.44 | 48 |
Short-Term Debt Repaid | - | - | - | -126 | -20 | -28 |
Long-Term Debt Repaid | - | -96.65 | -30.2 | -101.16 | -2.87 | - |
Total Debt Repaid | -128.21 | -96.65 | -30.2 | -227.16 | -22.87 | -28 |
Net Debt Issued (Repaid) | -42.11 | 58.15 | 49.24 | -120.46 | 32.57 | 20 |
Issuance of Common Stock | - | - | - | 104.68 | 14.76 | - |
Repurchase of Common Stock | - | - | - | - | -38.34 | -1.66 |
Common Dividends Paid | -141.1 | -187.72 | -156.2 | -124.01 | -58.61 | -31.14 |
Other Financing Activities | 8.61 | 29.02 | 21.26 | -49.65 | 9.01 | -29.73 |
Financing Cash Flow | -174.6 | -100.56 | -85.7 | -189.44 | -40.6 | -42.52 |
Net Cash Flow | -29.94 | -113.2 | 105.39 | -116.77 | 214.69 | -81.81 |
Free Cash Flow | 160.45 | 113.98 | 203.89 | 147.9 | 191.77 | 79.96 |
Free Cash Flow Growth | 75.47% | -44.10% | 37.85% | -22.88% | 139.84% | 1457.10% |
Free Cash Flow Margin | 5.05% | 3.25% | 4.84% | 4.06% | 5.81% | 3.26% |
Free Cash Flow Per Share | 1.06 | 0.75 | 1.33 | 0.97 | 1.26 | 0.52 |
Cash Income Tax Paid | 190.87 | 202.29 | 278.4 | 255.07 | 227.7 | 145.92 |
Levered Free Cash Flow | 217.91 | 122.08 | 143.06 | -27.82 | 261.85 | 125.69 |
Unlevered Free Cash Flow | 225.17 | 130.17 | 145.37 | -24.82 | 267.29 | 126.04 |
Change in Working Capital | -12.64 | -12.64 | -100.28 | -134.56 | -0.74 | 45.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.